Methods of treating skin disorders using an IL-31RA antagonist

Details for Australian Patent Application No. 2006214404 (hide)

Owner Bristol-Myers Squibb Company

Inventors Bilsborough, Janine

Agent Griffith Hack

Pub. Number AU-B-2006214404

PCT Pub. Number WO2006/088855

Priority 60/694,867 29.06.05 US; 60/653,283 14.02.05 US; 60/716,761 13.09.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 8 March 2012

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/088855 Priority application(s): WO2006/088855

8 March 2012 Application Accepted

  Published as AU-B-2006214404

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214407-Valved fluid connector

2006214400-Modular head lamination device and method